EMAIL THIS PAGE TO A FRIEND

Cancer letters

The tSP Motif in aP180 inhibits phospholipase d1 activity resulting in increased efficacy of anticancer drug via its direct binding to carboxyl terminal of phospholipase d1.


PMID 21296491

Abstract

We're sorry this abstract is currently not available.